You are here

Funding

Rosendo Garganta
07.06.2016

The investment valued at €850,000 was led by Emesa Corporación Empresarial, owned by Emilio Cuatrecasas

Carlos Buesa, CEO Oryzon
09.05.2016

The company has signed loan agreements with banking institutions on top of the €16.5-millions capital increase at the end of last year

Equip IDP Pharma
18.05.2016

The company is working on new agents to treat leukemia, particularly multiple myeloma

Equip Ability Pharma
12.05.2016

The Catalan firm has granted an exclusive license for its anticancer agent, potentially valued at more than €20 millions

laura soucek
10.05.2016

The spin-off of the Vall d’Hebron Institute of Oncology (VHIO) and ICREA will put most of the funds towards preclinical validation of a treatment for multiform glioblastoma, one of the most aggressive brain tumors

Recerca
11.05.2016

The "Business plan aggregator" awards and the "Headstart" and "Proof of concept" calls for proposals are geared towards business ideas, SMEs, spinoffs and startups

Equip Cebiotex
04.05.2016

Through the spin-off Cebiotex, the project has launched a round of crowdfunding to make sure the product is also applied to childhood cancers

IUCT
07.04.2016

The group hopes to develop two products in two years for this disease, which is the most common form of muscular dystrophy in adults

Fundadors d'STAT Diagnostica
12.04.2016

The Dutch investor Gilde Healthcare led the round of financing together with six investors who already hold shares in the company

Jaume Amat
17.03.2016

The Sánchez Lafuente family (who formerly owned 'Gelocatil') and Carlos Aparicio led the round